echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Professor Chen Qijun's research group revealed that dihydroartemisinin regulates spleen immune cell heterogeneity through SOD3-JNK-AP-1 signaling pathway

    Professor Chen Qijun's research group revealed that dihydroartemisinin regulates spleen immune cell heterogeneity through SOD3-JNK-AP-1 signaling pathway

    • Last Update: 2022-05-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dihydroartemisinin (DHA) is a derivative of artemisinin
    .

    Not only is it the drug of choice for the treatment of malaria, it is also used to treat autoimmune diseases such as systemic lupus erythematosus and psoriasis
    .

    After DHA was first reported to have immunomodulatory effects in the 1990s, more and more evidences have shown that DHA can modulate the body's immune system, but its underlying regulatory mechanism remains to be revealed
    .

    Recently, Professor Chen Qijun's research group from Shenyang Agricultural University published a research paper entitled "Dihydroartemisinin beneficially regulates splenic immune cell heterogeneity through the SOD3-JNK-AP-1 axis" in Science China Life Sciences, revealing that DHA regulates SOD3-JNK- AP-1 signaling pathway regulates the body's immune system
    .

    In a previous study, Prof.
    Qijun Chen's group found that DHA can cause the rearrangement of immune cells in the spleen of mice (Zhang et al.
    , Science China Life Sciences, 2020)
    .

    On this basis, the research group used single-cell transcriptome sequencing technology to construct the first cellular transcriptional map of DHA-regulated spleen immune cell subsets
    .

    In terms of cellular immunity, the research group found and verified that the proportion of spleen regulatory T cells (Treg) and CD8+IFN-γ+cytotoxic T cells was significantly increased after DHA intervention
    .

    At the same time, Treg highly expressed inhibitory signal molecules such as CD73, CD274 and IL-10, while the expression of key effector molecules granzyme A and granzyme B in CD8+IFN-γ+ cytotoxic T cells was down-regulated
    .

    In terms of humoral immunity, the research group found that after DHA intervention, the expression of MHCII molecules in spleen follicular B cells was down-regulated; at the same time, the expression levels of key molecules (CD79a, CD79b and Ms4a1) related to B cell activation in follicular B cells were also decreased.
    Significant down-regulation
    .

    These results suggest that DHA has distinct effects on humoral and cellular immunity
    .

    Analysis of KEGG enrichment and differential gene expression showed that DHA significantly up-regulated the expression of Activating Protein-1 (AP-1) transcription factor in various immune cells
    .

    The research group used flow cytometry and Western Blot and other experimental techniques to confirm that the changes in the expression of AP-1 and its upstream kinase JNK are indeed regulated by DHA
    .

    Studies have shown that superoxide dismutase 3 (SOD3), as a growth regulator, can drive the activation of AP-1
    .

    The research group used SOD3 knockout mice to study, and confirmed that SOD3 knockout can inhibit DHA-induced immune cell rearrangement and activation of JNK-AP-1 signaling pathway
    .

    This indicates that the immunoregulatory function of DHA is indeed closely related to the activation of SOD3-JNK-AP-1 signaling pathway
    .

    This study lays a foundation for in-depth understanding and revealing of the immune regulation function and molecular mechanism of DHA
    .

    Figure 1.
    DHA-mediated immune regulation in the spleen and its underlying mechanisms.
    Lecturer Zhang Yiwei, Dr.
    Li Qilong and Professor Jiang Ning from the School of Animal Science and Medicine, Shenyang Agricultural University are the co-first authors of the article, and Professor Chen Qijun is the corresponding author
    .

    For details, please read the original text▼[Click the link below or read the original text]Zhang, Y.
    , Li, Q.
    , Jiang, N.
    , Su, Z.
    , Yuan, Q.
    , Lv, L.
    , Sang, X.
    , Chen , R.
    , Feng, Y.
    , and Chen, Q.
    (2022).
    Dihydroartemisinin beneficially regulates splenic immune cell heterogeneity through the SOD3-JNK-AP-1 axis.
    Sci China Life Sci 65, https://doi.
    org/ 10.
    1007/s11427-021-2061-7
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.